Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Hillstream BioPharma Hillstream BioPharma Provides Business Review with Key Pipeline Updates February 14, 2022 From Hillstream BioPharma Via AccessWire Tickers HILS SAVE THE DATES: Hillstream BioPharma Announces R&D Day on February 24, 2022 and Business Review on Monday February 14, 2022 February 11, 2022 From Hillstream BioPharma Via AccessWire Tickers HILS Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting HSB-510, a Novel Quatramer-based, First-in-Class Dual Inhibitor of HDAC6 and PI3K-delta Downregulating c-myc Expression February 01, 2022 From Hillstream BioPharma Via AccessWire Tickers HILS Hillstream BioPharma and University of Massachusetts Chan Medical School Announce Research Collaboration using CRISPR and Computational Approaches to Advance The Hillstream Ferroptomic Atlas January 26, 2022 From Hillstream BioPharma Via AccessWire Tickers HILS Hillstream BioPharma Announces Closing of Initial Public Offering January 14, 2022 From Hillstream BioPharma Via AccessWire Tickers HILS Hillstream BioPharma Announces Pricing of Initial Public Offering January 11, 2022 From Hillstream BioPharma Via AccessWire Tickers HILS Hillstream BioPharma and Minotaur Therapeutics Sign Term Sheet to Advance Next-Generation Targeted Knob Biologics for Undruggable Targets August 05, 2021 From Hillstream BioPharma Via AccessWire Topics Artificial Intelligence Exposures Artificial Intelligence COVID-19 Hillstream BioPharma Expands the Scientific Advisory Board with the Addition of Leading Innovator in the Study of Ferroptosis and Cancer, Scott Dixon, Ph.D. July 13, 2021 From Hillstream BioPharma Via AccessWire Topics Artificial Intelligence Exposures Artificial Intelligence COVID-19 Hillstream BioPharma Announces Abstract at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Highlighting HSB-1216’s Effect in Triple Negative Breast Cancer (TNBC) June 02, 2021 From Hillstream BioPharma Via AccessWire Topics Artificial Intelligence Exposures Artificial Intelligence COVID-19 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.